Wed, 8 May 2019
Earnings season continues to heat up and several medical device makers have reported their first-quarter results. In this episode of Industry Focus: Healthcare, host Shannon Jones and Brian Feroldi discuss why Abiomed (NASDAQ:ABMD) and Intersect ENT (NASDAQ:XENT) are off to a rough start in 2019 and why things couldn't be going better for Insulet (NASDAQ:PODD) and Novocure(NASDAQ:NVCR).
Stocks mentioned: ABMD, XENT, PODD, and NVCR
Check out more of our content here: